New generation antipsychotic drugs and compliance behaviour

@article{Voruganti2008NewGA,
  title={New generation antipsychotic drugs and compliance behaviour},
  author={L. Voruganti and L. Baker and A. Awad},
  journal={Current Opinion in Psychiatry},
  year={2008},
  volume={21},
  pages={133–139}
}
  • L. Voruganti, L. Baker, A. Awad
  • Published 2008
  • Medicine, Psychology
  • Current Opinion in Psychiatry
  • Purpose of review Antipsychotic therapy has been eclipsed by high rates of noncompliance; the problem was attributed to a lack of efficacy and the burden of side effects of neuroleptics. This review sought to examine whether the arrival of second generation (atypical) antipsychotic drugs with low side-effect liability and improved efficacy has helped to positively reinforce compliance behaviour among people treated for schizophrenia. Recent findings The number of studies that systematically… CONTINUE READING

    Topics from this paper.

    Progress in Defining Optimal Treatment Outcome in Schizophrenia
    • 64
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 65 REFERENCES